Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study

H. G. Nuesslein, R. Alten, M. Galeazzi, H. -M. Lorenz, M. T. Nurmohamed, W. G. Bensen, G. R. Burmester, H. -H. Peter, P. Peichl, K. Pavelka, M. Chartier, C. Poncet, C. Rauch, M. Le Bars

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)489-499
JournalClinical and Experimental Rheumatology
Issue number3
Publication statusPublished - 2016

Cite this